UCSF Rosenman Institute Timeline

Since our founding in 2014, we’ve become a critical part of the Bay Area’s health technology ecosystem. But we’re really just getting started! Join us to continue growing, building and impacting patient outcomes.

Institute Expands Programs, Receives Accolades

Rosenman responds to global pandemic by launching “ADAPT” accelerator program for startups with technologies addressing COVID-19.

Zeto Technologies raises $7.3M in Series A funding for its wireless EEG headset.

The San Francisco Business Times taps Rosenman founder Christine Winoto as one of the most influential women in Bay Area business.

CipherBio, an affiliate of Silicon Valley Bank, ranks Rosenman one of the nation’s top life science accelerators.

Cumulative FDA 510(k) approvals for Rosenman companies total 32.


14 FDA Approvals and $119 Million in Funding

By 2019, startups in the Rosenman network had obtained 25 510(k) medical device clearances from the FDA.

Start-ups in the Rosenman network attracted $119 million in seed-stage and VC investment, highlighting the quality of  leadership, potential for economic growth, and investor confidence that they could take their technologies to market.


MTVP Launches; Tueo Health Acquired; and Record Numbers Attend Rosenman Symposium

MedTech Venture Partners is launched, raising $31 million for its first fund. MTVP now backs a portfolio of 10 companies.

Rosenman Innovator company Tueo Health is acquired by Apple.

More than 1100 people register for the fifth annual Rosenman Symposium, a premier event the Bay Area healthtech calendar.


First Rosenman Innovator Company Acquired

Sontina Medical, a startup in the very first Rosenman Innovator cohort (2016) that was developing new instrumentation for breast biopsy, is acquired by industry leader CR Bard.


First Rosenman Innovator Cohort Selected

In June 2016 we announced the first-ever Rosenman Innovator cohort. The entrepreneurs are selected from a wide field of applicants from across the globe, and chosen based on their inventive technologies and market promise. The Rosenman Innovator program is the cornerstone of the Institute today.


Advisory Board Appointed and First Rosenman Scholars Arrive

In a critical move for the future, Rosenman appoints a stellar group of industry veterans to advise us on strategy and help make key connections.

In partnership with the territorial government of New South Wales, we begin hosting Australian healthtech entrepreneurs for two-year placements at our UCSF incubator. Sheridan Gho and Michael Weaver, co-founders of Cenofex Innovations, arrive to develop their smart sleeve for lymphedema.


Institute Launches with Rosenman Symposium, Welcomes Engineering Interns

In June 2014, motivated to carry on the legacy of Dan Rosenman, we launched the UCSF Rosenman Institute at the inaugural Rosenman Symposium, bringing together entrepreneurs, industry, academia, clinicians, and the entire healthtech community.

We welcome five talented engineering undergraduates from Scotland’s Saltire Foundation (now Entrepreneurship Scotland), whom we placed with startups to get a taste of high-growth entrepreneurship, Bay Area-style. This program continues continues today, and draws rave reviews.